Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives, National Academy of Medicine, join Lori Ellis, head of insights, to discuss the evolution of women's inclusion in clinical trials.

They note that while overall representation has improved, significant challenges remain. They highlight how industry mindset has evolved from being protectionist to inclusion.

This episode is presented in partnership with DIA, in support of their 2025 Global Annual Meeting taking place June 15-19 in Washington DC.

Host

⁠⁠⁠⁠Lori Ellis⁠⁠⁠⁠, Head of Insights, BioSpace

Guests

Martin Hodosi, Partner, Kearney

Melissa Laitner, Director of Strategic Initiatives, National Academy of Medicine

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials

BioSpace

Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials